FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

84746004: Pituitary hormone (substance)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
140496012 Pituitary hormone en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
826654011 Pituitary hormone (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
140496012 Pituitary hormone en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
140496012 Pituitary hormone en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
826654011 Pituitary hormone (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
826654011 Pituitary hormone (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core


49 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Pituitary hormone Is a Hypothalamic and pituitary hormone false Inferred relationship Existential restriction modifier (core metadata concept)
Pituitary hormone Is a Pituitary or adrenal hormone false Inferred relationship Existential restriction modifier (core metadata concept)
Pituitary hormone Has disposition Pituitary hormone (disposition) true Inferred relationship Existential restriction modifier (core metadata concept)
Pituitary hormone Is a Hormone true Inferred relationship Existential restriction modifier (core metadata concept)
Pituitary hormone Is a Substance with molecular messenger mechanism of action (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
Pituitary hormone Is a hormones et leurs métabolites et précurseurs false Inferred relationship Existential restriction modifier (core metadata concept)

Inbound Relationships Type Active Source Characteristic Refinability Group
Follitropin beta 300iu injection solution cartridge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Follitropin beta 600iu injection solution cartridge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Pituitary follicle stimulating hormone-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Somatropin [2] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Follitropin alfa 600units/mL injection solution 3mL prefilled pen The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Recombinant human follicle stimulating hormone alpha 450iu injection (pdr for recon)+diluent The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Recombinant human follicle stimulating hormone alpha 1050iu injection (pdr for recon)+diluent The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Somatrem 5mg/vial injection (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Somatrem 10 mg powder for solution for injection vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Follitropin beta 75iu/vial powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Follitropin alfa 150units/amp injection (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Follitropin alfa 75iu/amp powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Somatropin 10mg/vial solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Somatropin 10mg/2mL solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Somatropin 1.6mg powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Somatropin 1.2mg powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Somatropin 2mg powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Somatropin 0.8mg The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Somatropin 2.0mg/.25mL powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Somatropin 13.8mg powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Somatropin 1.5mg powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Somatropin 1.4mg powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Somatropin 0.2mg The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Somatropin 5.8mg powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Somatropin 1.4mg/.25mL powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Somatropin 1.6mg/.25mL powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Somatropin 1.2mg/.25mL powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Somatropin 0.8mg/unt powder (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Somatropin 0.6mg/unt powder (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Somatropin 1.8mg powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Somatropin 0.44mg/unit powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Somatropin 1.8mg/.25mL powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Somatropin 1.0mg The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Somatropin 0.4mg The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely pituitary follicle stimulating hormone 75 unit and pituitary luteinizing hormone 75 unit/1 vial powder for conventional release solution for injection (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Pituitary follicle stimulating hormone 150 unit and pituitary luteinising hormone 150 unit powder for solution for injection vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Anterior pituitary hormone-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Follitropin beta 900iu injection solution cartridge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Recomb human follicle stim horm alpha 1200iu powder and solvent for injection solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Cosyntropin 50mcg/mannitol 10mg injection solution vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Sermorelin acetate 0.5mg/vial powder for injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Somatropin 12mg/vial powder for injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Somatropin 0.6mg/vial powder for injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Somatropin 15mg/1.5mL injection solution 1.5mL cartridge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Somatropin 5.0mg/1.5mL injection solution 1.5mL cartridge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Sermorelin acetate 1.0mg/vial powder for injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Somatropin 5mg/vial powder for injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Somatropin 10mg/vial powder for injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Somatropin 6mg/vial powder for injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Sermorelin acetate 50mcg/vial powder for injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Somatropin 10.0mg/1.5mL injection solution 1.5mL cartridge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Anterior pituitary hormone Is a False Pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Poisoning by pituitary hormone Causative agent (attribute) True Pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept) 1
Anterior pituitary hormone Is a True Pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Pituitary hormone allergy Causative agent (attribute) True Pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept) 1
Corticotropic agent Is a False Pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Somatotrophin poisoning of undetermined intent Causative agent (attribute) False Pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Melanocyte stimulating hormone analog Is a False Pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Prolactin Is a False Pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Human follicle stimulating hormone Is a False Pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Poisoning caused by somatotropin Causative agent (attribute) False Pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Intentional thyrotrophic hormone poisoning Causative agent (attribute) False Pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Accidental somatotrophin poisoning Causative agent (attribute) False Pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Intentional somatotrophin poisoning Causative agent (attribute) False Pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Thyrotrophic hormone poisoning Causative agent (attribute) False Pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Accidental thyrotrophic hormone poisoning Causative agent (attribute) False Pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Thyrotrophic hormone poisoning of undetermined intent Causative agent (attribute) False Pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Human menopausal gonadotropin Is a False Pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Poisoning caused by anterior pituitary hormone (disorder) Causative agent (attribute) False Pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Pituitary follicle stimulating hormone Is a False Pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)
Lipotropin Is a False Pituitary hormone Inferred relationship Existential restriction modifier (core metadata concept)

Start Page 2 of 2


This concept is not in any reference sets

Back to Start